News
18th Congress of European Crohn’s and Colitis Organisation in Copenhagen
From 1st - 4th of March 2023 the 18th Congress of ECCO took place in the Bella Center in Copenhagen. The participants enjoyed the fascinating Scientific Programme revolving around the theme of “Sequen...
Make Your Results Matter: Join the Webinar ‘Horizon Results Platform & Partners: A Value Proposition’
Since its launch in 2019, the Horizon Results Platform has been offering a free, online space where participants of EU-funded projects, such as Horizon 2020 and Horizon Europe, can advertise the resul...
ImmUniverse: position paper just published
ImmUniverse has just published a position paper in Frontiers in Immunology, which highlights the current unmet need for treatment of immune mediated inflammatory diseases and emphasises that an advanc...
Join the European Research and Innovation Days 2022 Online on 28 & 29 September
The European Research and Innovation Days are the European Commission’s annual flagship Research and Innovation event, bringing together policymakers, researchers, entrepreneurs and the public to deba...
Recruitment begins for novel biosampling approach in Kiel, Germany, for patients with Atopic Dermatitis
Using a recently developed, minimally invasive technology known as dermal open flow microperfusion (dOFM), researchers from the University Hospital Kiel, Germany, and the Joanneum, Austria, will g...
ImmUniverse partners meet in person for the first time to hold successful annual meeting
On 24th of February 2020, the ImmUniverse partners were supposed to meet for the first time. With the first COVID-related death announced in Italy only two days prior, the meeting was cancelled very l...
ImmUniverse partner Scuola Superiore Sant'Anna presents results on Low Intensity Pulsed Ultrasound stimulation during recent workshop
A joint scientific workshop between the Biorobotics Institute of Scuola Superiore Sant'Anna and the Italian Institute of Technology was organised at Polo Sant’Anna Valdera in Pontedera (Italy) on May...
First data presented from ImmUniverse prospective study
Florian Tran of ImmUniverse partner Christian-Albrechts-Universität Kiel just recently presented first data from the cohort of ulcerative colitis patients taking part in the prospective study of Imm...
ImmUniverse partner ITTM participating in IHI webinar
Small and medium-sized enterprises (SMEs) are key players in the European pharmaceutical research and development landscape. In projects of the Innovative Health Initiative (IHI), SMEs act as a key in...
ImmUniverse: first annual progress report available for download
After a turbulent first project year highly impacted by the COVID-19 pandemic, the project team nevertheless continued unperturbed in advancing the research into a more personalised identification and...
ImmUniverse prospective clinical study has started: first patients enrolled
To advance the understanding of the molecular mechanisms underlying the two diseases under study in the project, ulcerative colitis (UC) and atopic dermatitis (AD), a prospective observational study c...
Coordinator Prof. Silvio Danese introduces ImmUniverse at ueg week
From 11-13 October 2020 the ueg week, the yearly conference hosted by United European Gastroenterology, took place virtually. During the session ‘Research over Lunch’, Prof. Silvio Danese, Head of...
Official launch of ImmUniverse
By looking into the common disease mechanisms of Ulcerative Colitis and Atopic Dermatitis, the 26 European partners collaborating in the new research project ImmUniverse aim at improving diagnostic an...